Citigroup
MIST icon

Citigroup’s Milestone Pharmaceuticals MIST Stock Holding History

Citigroup’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,858
Closed -$68.4K – 6213
2025
Q4 		$68.4K Buy
33,858
+26,046
+333% +$56.1K ﹤0.01% 4473
2025
Q3 		$15.6K Buy
+7,812
New +$13.7K ﹤0.01% 4893
2025
Q2 		– Sell
-2
Closed -$2 – 5812
2025
Q1 		$2 Sell
2
-327
-99% -$650 ﹤0.01% 5517
2024
Q4 		$776 Buy
+329
New +$565 ﹤0.01% 5612

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Citigroup's MIST Position: Q1 2026 in Review

Citigroup sold out of Milestone Pharmaceuticals (MIST) in Q1 2026, closing a stake of 33,858 shares — an estimated $68.4K sold.

Citigroup first reported a position in MIST in Q4 2024 and held it in 4 quarters. The position peaked at $68.4K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Citigroup reported no remaining Milestone Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 33,858 Milestone Pharmaceuticals shares in Q1 2026, an estimated $68.4K.
  • Citigroup first reported a position in Milestone Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Citigroup's Milestone Pharmaceuticals position peaked at $68.4K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.